168 related articles for article (PubMed ID: 26699825)
1. Proton pump inhibitors, histamine-2 receptor antagonists, gastroprotection and lower gastrointestinal tract bleeding in low-dose aspirin users.
Fernández-Fernández FJ; Ameneiros-Lago E; Sesma P; Pía G
Dig Liver Dis; 2016 Feb; 48(2):211. PubMed ID: 26699825
[No Abstract] [Full Text] [Related]
2. Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease.
Miyake K; Akimoto T; Hanada Y; Nagoya H; Kodaka Y; Ueki N; Kusunoki M; Kawagoe T; Futagami S; Takahashi Y; Takano H; Sakamoto C
Dig Liver Dis; 2015 Sep; 47(9):757-62. PubMed ID: 26105589
[TBL] [Abstract][Full Text] [Related]
3. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
[TBL] [Abstract][Full Text] [Related]
5. Prevention of damage induced by aspirin in the GI tract.
Scheiman JM
Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):153-62. PubMed ID: 22542153
[TBL] [Abstract][Full Text] [Related]
6. PPIs Prevent Aspirin-Induced Gastrointestinal Bleeding Better than H2RAs. A Systematic Review and Meta-analysis.
Szabó IL; Mátics R; Hegyi P; Garami A; Illés A; Sarlós P; Bajor J; Szűcs A; Mosztbacher D; Márta K; Szemes K; Csekő K; Kővári B; Rumbus Z; Vincze Á
J Gastrointestin Liver Dis; 2017 Dec; 26(4):395-402. PubMed ID: 29253055
[TBL] [Abstract][Full Text] [Related]
7. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
Vaduganathan M; Bhatt DL; Cryer BL; Liu Y; Hsieh WH; Doros G; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Cannon CP;
J Am Coll Cardiol; 2016 Apr; 67(14):1661-71. PubMed ID: 27012778
[TBL] [Abstract][Full Text] [Related]
8. [Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].
Nardulli G; Lanas A
Gastroenterol Hepatol; 2009 Jan; 32(1):36-43. PubMed ID: 19174098
[TBL] [Abstract][Full Text] [Related]
9. Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding.
Sáez ME; González-Pérez A; Johansson S; Nagy P; García Rodríguez LA
Am J Cardiovasc Drugs; 2014 Dec; 14(6):443-50. PubMed ID: 25119521
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of stress induced ulcers: histamine-2 receptor antagonists or proton pump inhibitors? - gastric hemorrhage occur more often under proton pump inhibitors].
Tank S; Kerner T
Dtsch Med Wochenschr; 2014 Jun; 139(25-26):1338. PubMed ID: 24914510
[No Abstract] [Full Text] [Related]
11. H2 Receptor Antagonists versus Proton Pump Inhibitors in Patients on Dual Antiplatelet Therapy for Coronary Artery Disease: A Systematic Review.
Almufleh A; Ramirez FD; So D; Le May M; Chong AY; Torabi N; Hibbert B
Cardiology; 2018; 140(2):115-123. PubMed ID: 29966126
[TBL] [Abstract][Full Text] [Related]
12. Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs.
Takada M; Fukumoto K; Shibakawa M
J Clin Pharm Ther; 2004 Apr; 29(2):183-7. PubMed ID: 15068408
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients.
Cook D; Guyatt G
N Engl J Med; 2018 Jun; 378(26):2506-2516. PubMed ID: 29949497
[No Abstract] [Full Text] [Related]
14. Proton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysis.
Zhang YS; Li Q; He BS; Liu R; Li ZJ
World J Gastroenterol; 2015 May; 21(20):6341-51. PubMed ID: 26034370
[TBL] [Abstract][Full Text] [Related]
15. Effects of gastric medicines on gastroduodenal injury in patients with stable angina during antiplatelet therapy.
Hokimoto S; Matsui K; Oshima S; Noda K; Kaikita K; Sumida H; Sugiyama S; Ogawa H
J Cardiol; 2009 Aug; 54(1):71-5. PubMed ID: 19632523
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
17. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
Morini S; Zullo A
G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
[No Abstract] [Full Text] [Related]
18. Efficacy of H2 receptor antagonists for prevention of upper gastrointestinal bleeding during dual-antiplatelet therapy.
Yasu T; Sato N; Kurokawa Y; Saito S; Shoji M
Int J Clin Pharmacol Ther; 2013 Nov; 51(11):854-60. PubMed ID: 24040853
[TBL] [Abstract][Full Text] [Related]
19. A COGENT Argument for Gastrointestinal Protection With Low-Dose Aspirin.
Farkouh ME
J Am Coll Cardiol; 2016 Apr; 67(14):1672-3. PubMed ID: 27012779
[No Abstract] [Full Text] [Related]
20. Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in Japan.
Ishikawa S; Inaba T; Mizuno M; Okada H; Kuwaki K; Kuzume T; Yokota H; Fukuda Y; Takeda K; Nagano H; Wato M; Kawai K
Acta Med Okayama; 2008 Feb; 62(1):29-36. PubMed ID: 18323869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
